The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
I see upside back to above $70 regardless of whether the company gets taken private.
M&A activity has generally slowed.
With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.
A drop in shares doesn't necessarily mean it's time to turn the channel on Viacom, as details of expected merger with CBS will prove 'paramount.'
A rundown of several oil companies that could soon be on the block.
Lyft's IPO is looking like a party bus, but how long can the sentiment stay strong?
Goldman is top of the heap for takeovers.
One of pharma's biggest CEO's talks M&A action on the exchange.
Big pharma could be primed for an M&A Boom after Bristol-Myers Squibb's blockbuster deal for Celgene.